Evidence map›Paper›PMID 42151124›Full record

ArticleCell death & disease2026

Correction: SPHK1 promotes bladder cancer metastasis via PD-L2/c-Src/FAK signaling cascade.

Wei-Hsiang Kao, Li-Zhu Liao, Yu-An Chen, U-Ging Lo, Rey-Chen Pong, Elizabeth Hernandez, Mei-Chih Chen, Chieh-Lin Jerry Teng, Hsin-Yi Wang, Stella Chin-Shaw Tsai and 4 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell death & disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Wei-Hsiang KaoDepartment of Life Sciences, National Chung Hsing University, Taichung, Taiwan.
Li-Zhu LiaoDepartment of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Yu-An ChenDepartment of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
U-Ging LoDepartment of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Rey-Chen PongDepartment of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Elizabeth HernandezDepartment of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Mei-Chih ChenTranslational Cell Therapy Center, China Medical University Hospital, Taichung, Taiwan.
Chieh-Lin Jerry TengDivision of Hematology/Medical Oncology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
Hsin-Yi WangDepartment of Nuclear Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
Stella Chin-Shaw TsaiDepartment of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.
Payal KapurUrology and Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID http://orcid.org/0000-0002-4239-0495
Chih-Ho LaiDepartment of Microbiology and Immunology, Chang Gung University, Taoyuan, Taiwan.
Jer-Tsong HsiehDepartment of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA. JT.Hsieh@utsouthwestern.edu.ORCID http://orcid.org/0000-0002-1919-6010
Ho LinDepartment of Life Sciences, National Chung Hsing University, Taichung, Taiwan. hlin@dragon.nchu.edu.tw.ORCID http://orcid.org/0000-0001-7849-9137

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42151124
PMCPMC13184309

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.